Frontiers in Pharmacology | Respiratory Pharmacology

Case Report

Published on 02 Jul 2025

Case Report: Omalizumab combined with voriconazole for the treatment of ABPA complicating IPA: a case report

in Respiratory Pharmacology

Tingrui Zhao
Yukai Chen
He Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1588182

208 views

Review

Accepted on 30 Jun 2025

Mapping the Oxidative Landscape in Cystic Fibrosis: Methodological Frontiers and Application

in Respiratory Pharmacology

Giorgio Cozza
Michela Rubin
Ilaria Artusi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632924

Case Report

Accepted on 27 Jun 2025

Case Report: Coadministration of TNF-α Blockade as an Effective Adjunctive Strategy in the Treatment of ANCA-Negative EGPA with Refractory Peripheral Neuropathy

in Respiratory Pharmacology

Dabin Tang
Yubao Jiang
Shuo Yang
Jiaxin Wei
Jingjing Xie
Jianyong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555377

110 views

Review

Published on 26 Jun 2025

Oxidative stress in ARDS: mechanisms and therapeutic potential

in Respiratory Pharmacology

Fengyun Wang
Ruiqi Ge
Yun Cai
Mingrui Zhao
Zhen Fang
Jingguo Li
Chengzhi Xie
Mei Wang
Wanyue Li
Xiaozhi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1603287

354 views

Original Research

Published on 25 Jun 2025

Role and mechanism of IGFBP5 in the real-ambient particulate matter exposure-induced chronic lung injury

in Respiratory Pharmacology

Ningning Chen
Yuan Qi
Wanli Ma
Xiaoxiao Zhu
Xiaoying Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1604301

271 views

Case Report

Published on 25 Jun 2025

Case Report: Polymyxin B-induced anaphylactic shock

in Respiratory Pharmacology

Weiqian Liu
Bo Gao
Shaowei Xie
Yu Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594127

266 views

Editorial

Accepted on 19 Jun 2025

Editorial: Use of Bioactives for Treatment of Respiratory Diseases

in Respiratory Pharmacology

Alan de Aguiar Lopes
Akinori Nagato
Frank Silva Bezerra
Samuel Dos Santos Valença
Sabina Antonela Antoniu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1630486

132 views

Original Research

Published on 19 Jun 2025

Drug-related problems in elderly patients with AECOPD and pharmaceutical intervention practice: a prospective study

in Respiratory Pharmacology

Zengqing Ma
Hongjun Shi
Guojun Hong
Lianping Wu
Yu Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596795

414 views

Original Research

Published on 18 Jun 2025

Oral Angiotensin-(1-7) formulation after established elastase-induced emphysema suppresses inflammation and restores lung architecture

in Respiratory Pharmacology

Giselle Santos Magalhaes
Alicia Villacampa
Maria Gloria Rodrigues-Machado
Maria Jose Campagnole-Santos
Robson Augusto Souza Santos
Carlos F. Sánchez-Ferrer
Concepción Peiró

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540475

446 views

Original Research

Accepted on 16 Jun 2025

EPA-Lactone derivative, 5,6-diHETE lactone, improves pulmonary arterial hypertension in a monocrotaline-induced model

in Respiratory Pharmacology

KARTHIK DHANANJAYAN
Offir Ertracht
Shaul Atar
Andrea Szuchman-Sapir

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1621030

153 views

Original Research

Accepted on 16 Jun 2025

Novel mitophagy inducer TJ0113 alleviates pulmonary inflammation during acute lung injury

in Respiratory Pharmacology

Zhengyuan Liu
Danruo Fang
Kaijun Chen
Lingling Dong
Huaqiong Huang
Zhihua Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590458

151 views

Original Research

Published on 13 Jun 2025

Clinical features and genetic spectrum of children with primary ciliary dyskinesia in central China: a referral center retrospective analysis

in Respiratory Pharmacology

Xiaoning Zhang
Xiuhong Jin
Zhiying Zhang
Yanqiong Wang
Xiangfeng Zhang
Zhen Dong
Haiming Yang
Yuelin Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1526675

526 views

Editorial

Published on 11 Jun 2025

Editorial: Applications of AI, machine learning, computational medicine, and bioinformatics in respiratory pharmacology

in Respiratory Pharmacology

Muhammad Ashad Kabir
Paolo Montuschi
Kuang-Ming Liao
Mojtaba Amani

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1602941

935 views

Original Research

Published on 05 Jun 2025

Machine learning-based prediction model for lung ischemia-reperfusion injury: insights from disulfidptosis-related genes

in Respiratory Pharmacology

Yanpeng Zhang
Jingyang Sun
Yihan Lin
Rongxuan Jiang
Niuniu Dong
Huanhuan Dong
Peng Li
Jinteng Feng
Zijiang Zhu
Guangjian Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545111

654 views

Original Research

Published on 05 Jun 2025

Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland

in Respiratory Pharmacology

Sebastian Majewski
Katarzyna Górska
Katarzyna B. Lewandowska
Magdalena M. Martusewicz-Boros
Małgorzata Sobiecka
Wojciech J. Piotrowski

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586197

1,014 views

Original Research

Published on 30 May 2025

Efficacy and safety of a new drug formulation, amoxicillin-clavulanate-cineole, for adult lower respiratory tract infections: a nationwide observational study in Morocco

in Respiratory Pharmacology

Mohamed Chakib Benjelloun
Youness El Achhab
Chakib Nejjari
the ORCA Study Group

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1549014

771 views